Science & News / Our Direction

Our Direction

From Laboratory to Clinic: Our Brand Direction

Connecting quality management, veterinary needs and care records through CDMO, veterinary drug development and FurNavi AI.

Behind every dog or cat entering a veterinary practice is a family hoping to make a better decision. As new care options emerge, pet parents need clear information. Veterinarians need traceable quality documentation and records that make subsequent changes visible.

Starting with Quality and Clinical Needs

Miracle Petgenix Biotech Co., Ltd. starts with animal health needs and emphasizes sourcing, process records and quality management. Drawing on our parent company Miracle Biomedical's experience in industrial development, we are gradually building collaboration and development pathways shaped by canine and feline needs and veterinary expertise.

Clear Roles for CDMO and Drug Development

CDMO (contract development and manufacturing) is a planned collaboration direction focused on product development, process establishment and quality documentation. Actual services depend on project conditions and mutual agreement. Veterinary drug development is a long-term direction: framing questions around clinical problems, accumulating data and advancing validation under applicable requirements.

FurNavi AI Connects Care Records

FurNavi AI starts with care workflows and helps organize pet health information, giving pet parents and veterinary teams a more complete basis for communication. The platform does not replace veterinary diagnosis or treatment. Any subsequent research use of data requires separate, appropriate authorization and data governance arrangements.

From the laboratory to the clinic, and from clinical observations to new research questions, we aim to work with veterinarians and industry partners to build more evidence-informed pet care, step by step.

← Back to Company News